Can Bostan, Ö. Et Al. 2023. Sinonasal and respiratory outcomes of eosinophilic granulomatosis with polyangiitis patients receiving 100 mg mepolizumab in real-life clinical practice: 1-year follow up study.. The Journal of asthma : official journal of the Association for the Care of Asthma , vol.60, no.5 , 931-937.

Can Bostan, Ö., Duran, E., Tuncay, G., Cihanbeylerden, M., Karadag, Ö., Damadoglu, E., ... Karakaya, G.(2023). Sinonasal and respiratory outcomes of eosinophilic granulomatosis with polyangiitis patients receiving 100 mg mepolizumab in real-life clinical practice: 1-year follow up study.. The Journal of asthma : official journal of the Association for the Care of Asthma , vol.60, no.5, 931-937.

Can Bostan, ÖZGE Et Al. "Sinonasal and respiratory outcomes of eosinophilic granulomatosis with polyangiitis patients receiving 100 mg mepolizumab in real-life clinical practice: 1-year follow up study.," The Journal of asthma : official journal of the Association for the Care of Asthma , vol.60, no.5, 931-937, 2023

Can Bostan, ÖZGE C. Et Al. "Sinonasal and respiratory outcomes of eosinophilic granulomatosis with polyangiitis patients receiving 100 mg mepolizumab in real-life clinical practice: 1-year follow up study.." The Journal of asthma : official journal of the Association for the Care of Asthma , vol.60, no.5, pp.931-937, 2023

Can Bostan, Ö. Et Al. (2023) . "Sinonasal and respiratory outcomes of eosinophilic granulomatosis with polyangiitis patients receiving 100 mg mepolizumab in real-life clinical practice: 1-year follow up study.." The Journal of asthma : official journal of the Association for the Care of Asthma , vol.60, no.5, pp.931-937.

@article{article, author={ÖZGE CAN BOSTAN Et Al. }, title={Sinonasal and respiratory outcomes of eosinophilic granulomatosis with polyangiitis patients receiving 100 mg mepolizumab in real-life clinical practice: 1-year follow up study.}, journal={The Journal of asthma : official journal of the Association for the Care of Asthma}, year=2023, pages={931-937} }